India  

"Serum Institute"

Latest news and video coverage curated from trusted media outlets

0
shares
ShareTweetSavePostSend
 

You Might Like


Karan on selling 50 per cent of Dharma to Poonawalla

In 2024, Karan Johar made headlines when he sold a 50 percent stake of his production company, Dharma Productions, to Serum Institute of India CEO Adar Poonawalla for a staggering Rs 1,000 crore. In a..
IndiaTimes - Published

SII CEO Adar Poonawalla buys Rs 1.04 crore matte black Land Rover Defender 110 X for...

Indian billionaires are known for their luxurious lifestyles, often accompanied by an impressive fleet of vehicles and security cars. Adar Poonawalla, CEO of Serum Institute of India, is no exception.
DNA - Published

After Anand Mahindra, Adar Poonawalla responds to L&T chief's 90-hour work week remark: 'My wife loves staring at me'

Adar Poonawalla, CEO of the Serum Institute of India, backed Mahindra Group Chairman Anand Mahindra's call for prioritising quality over quantity in work hours
DNA - Published

Karan posts cryptic message after Jaaved mocks deal

Karan Johar recently made waves in the industry by selling a 50 per cent stake in Dharma Productions to Adar Poonawalla, CEO of Serum Institute. Though the reason behind Johar’s search for an..
IndiaTimes - Published

Meet Pune's richest man who owns Rs 750 crore home, has net worth of over Rs 204300 crore, he is...

This is one of India's richest man who built the Serum Institute into the world's largest vaccine producer amassing a fortune of Rs 2,89,900 crore.
DNA - Published

Supreme Court bins pleas for probe into Covid jab side-effects

The Supreme Court dismissed a PIL seeking an investigation into alleged side effects of the Covishield vaccine, developed by AstraZeneca and Oxford and produced by Serum Institute of India. The..
IndiaTimes - Published

Serum Institute of India (SII) working on vaccine for Mpox outbreak: CEO Adar Poonawalla

Following the state government's guidelines on Mpox response, Serum Institute of India (SII) CEO Adar Poonawalla announced ongoing efforts to develop a vaccine, expecting positive results within a..
IndiaTimes - Published

Meet Indian, who owns over Rs 1400 crore mansion in London, much costlier than Mukesh Ambani, Lakshmi Mittal's UK homes

Serum Life Sciences, a UK-based subsidiary of the Poonawalla family's Serum Institute of India, will acquire the property, the reported quoted people familiar with the transaction as saying.
DNA - Published

Serum to buy 20% in med tech firm

Serum Institute of India (SII) invested in IntegriMedical, a med tech firm, for needle-free injection system tech. The partnership aims to provide 'health for all' and 'transform healthcare globally'..
IndiaTimes - Published

WHO approves Japan-made dengue vaccine

WHO approves TAK-003 (Qdenga) as 2nd dengue vaccine for children aged 6-16 in high-burden areas. Takeda in talks to launch in India. Panacea Biotec & Serum Institute collaborate on indigenous vaccine..
IndiaTimes - Published

1 in 3 Covaxin recipients hit by adverse events: Study

Nearly one-third of Covaxin recipients experienced adverse events of special interest within a year, including respiratory, skin, and musculoskeletal issues. The study also highlighted menstrual..
IndiaTimes - Published

TOI Health News Morning Briefing

Here is the TOI health news morning briefing. Legal action against Serum Institute over Covid deaths. AstraZeneca admits side effects. India reports FLiRT COVID variants. 91 cases of the new Covid-19..
IndiaTimes - Published

Kin claim deaths due to Covishield, to sue Serum Institute of India

Parents sue Covishield maker over side-effects deaths, halted production due to reduced demand post high vaccination rates. Legal action in Supreme Court confirmed vaccine as the cause of deaths.
IndiaTimes - Published

Covishield side effects disclosed in packaging: SII

Serum Institute of India stopped Covishield production due to reduced demand post high vaccination rates. They disclosed rare side effects like Thrombosis with thrombocytopenia syndrome since 2021,..
IndiaTimes - Published

Stopped producing Covishield in Dec 2021: SII after AstraZeneca recall

UK-based drug major AstraZeneca's decision to withdraw its Covid-19 vaccine globally, days after admitting to side effects, prompted Serum Institute of India to disclose that it had stopped..
IndiaTimes - Published

AstraZeneca withdraws COVID vaccine worldwide

AstraZeneca withdraws COVID vaccine worldwide due to TTS. Facing 100 million pound lawsuit. TTS involves blood clots, low platelets. Symptoms: severe headache, abdominal pain. Treatment: anticoagulant..
IndiaTimes - Published

Sharad Pawar seeks Bharat Ratna for Dr Poonawalla

Former Union minister Sharad Pawar on Wednesday heaped praises on Dr Cyrus Poonawalla, founder of Serum Institute of India (SII), for his work in the field of vaccine production, and demanded that he..
Mid-Day - Published

Meet woman, executive director of Rs 192000 crore company, known for glamorous and stylish life

Natasha Poonawalla, who is enthusiastic about fashion and design. She is currently serving as the executive director of the Serum Institute of India (SII), one of the biggest producers of vaccines..
DNA - Published

Meet Pune's richest man with net worth of Rs 166500 crore, is founder of world's largest pharmaceutical company, he is..

He played a crucial role as the leader of the Serum Institute of India in the large-scale production of the Covishield vaccine amid the Covid-19 pandemic.
DNA - Published

Adar Poonawala's mansion worth Rs 1446 crore

For those not aware of the name, Adar Poonawala is the CEO of Serum Institute of India, a company that achieved great success in vaccine making and distribution during the COVID pandemic.
IndiaTimes - Published

Imposition of tax on subsidies does not constitute 'taking away' of a benefit : Bombay HC; dismisses challenge by Serum Institute

The Bombay High Court dismissed a petition filed by Serum Institute of India Pvt Ltd challenging a 2016 amendment to the Income Tax Act, 2015. The amendment included subsidies, grants, and incentives..
IndiaTimes - Published

Meet man who owns exotic Rolls-Royce collection, cars worth over Rs 100 crore, not Mukesh Ambani, Ratan Tata, Adani

Yohan Poonawalla is son of Zavaray Poonawalla who co-founded biopharmaceuticals firm Serum Institute of India along with his brother Cyrus Poonawalla in 1966. The billionaire also owns private..
DNA - Published

Meet Yohan Poonawalla, Adar Poonawalla's cousin, collector with cars worth over Rs 100 crore, bigger than Mukesh Ambani

Yohan Poonawalla is the Chairman of Poonawalla Engineering Group and El-O- Matic India Pvt Ltd and he is also a shareholder in Serum Institute of India Pvt Ltd and Chairman of Poonawalla Financials Pvt..
DNA - Published

Cyrus Poonawalla: The Son Of A Horse Breeder Who Didn't Follow His Family's Footsteps But Carved His Own Path And Now Has A Net Worth Of Rs 2,25,000 Crore

Cyrus Poonawalla founded the Serum Institute of India (SII) in 1966, which is today the world's largest vaccine manufacturer.
Zee News - Published

Age is just a number, look at Ratan Tata, Bachchan: NCP Lok Sabha member Supriya Sule takes on Ajit Pawar

"Some people are saying that people who are senior now should give us their blessings (and retire). Why should they stop working? Ratan Tata who heads India's largest conglomerate is 86 years old...
IndiaTimes - Published

This man leads India's most valuable unlisted company worth Rs 1.92 lakh crore, not Mukesh Ambani, Ratan Tata, Adani

Adar Poonawalla's Serum Institute of India (SII), which became a household name for developing Covid-19 vaccines, is ranked as India's most valuable unlisted company,
DNA - Published

Bombay HC says content posted against Covishield vaccine prima facie defamatory

The Bombay High Court on Monday said content posted by two individuals and their organisations against vaccine manufacturing major Serum Institute of India (SII) was "prima facie defamatory" and..
Mid-Day - Published

Content posted against Serum Institute of India, its Covishield vaccine prima facie defamatory: Bombay HC

The Bombay high court on Monday said content posted by two individuals and their organisations against vaccine manufacturing major Serum Institute of India (SII) was "prima facie defamatory" and..
IndiaTimes - Published Also reported by •Mid-Day

A New Beacon of Education - Utkal Gaurav International School Shines Bright in the Remote Village of Berunapadi, Odisha

a new beacon of education - utkal gaurav international school shines bright in the remote village of berunapadi, odisha
Several titans of business, academics, sports, medicine and arts have come together in an unknown village Berunapadi, of Odisha, to commemorate the opening of the Utkal Gaurav International School..
NewsVoir - Published

Serum Institute to double investment in Biocon's unit to $300 million


IndiaTimes - Published

Covovax for adults to reach metros in a week: SII

Serum Institute of India’s CEO Adar Poonawalla told TOI on Friday that doses of Covovax — Covid booster shot for adults — would reach major cities in four to five days, while a Bharat Biotech..
IndiaTimes - Published

DNA Explainer: What is R21/Matrix-M, Oxford-Serum Institute's 'world-changer' malaria vaccine?

The R21 vaccine, created at Oxford University and approved by the Ghanaian Food and Drugs Authority, is now available to the age group most at risk of malaria-related mortality.
DNA - Published

SII to restart vaccine production amid surge in Covid cases

Serum Institute of India CEO Adar Poonawalla told TOI on Wednesday that the company has resumed production of its Covid-19 vaccine, Covishield, in response to the increasing number of SARS-CoV-2 virus..
IndiaTimes - Published

Serum Institute of India restarts manufacturing of Covid-19 vaccine Covishield

Serum Institute of India CEO Adar Poonawalla on Wednesday said the company has restarted manufacturing of Covid-19 vaccine Covishield amid rising numbers of cases of the virus infection. He said the..
IndiaTimes - Published

Serum Institute seeks inclusion of Covovax on CoWIN as heterologous booster dose for adults


IndiaTimes - Published Also reported by •Zee News

ET GrandMasters, an OTT Platform for Business Learning from Top Corporate Leaders of the Country

et grandmasters, an ott platform for business learning from top corporate leaders of the country
India's leading destination for consuming business & economy related news, Economic Times Digital has now launched a new OTT platform called *ET GrandMasters*. *ET GrandMasters, an OTT Platform from..
NewsVoir - Published

Serum Institute to set up CoE for Infectious Diseases and Pandemic Preparedness in Hyderabad


newKerala.com - Published

Serum Institute of India launches first made-in-India HPV vaccine for cervical cancer


newKerala.com - Published

DGCI approves market authorisation of Serum Institute's Covovax as booster dose


newKerala.com - Published

Drug panel favours nod for Covovax as Covid booster

An expert panel of the central drug regulatory authority has recommended market authorisation for Serum Institute of India’s Covid vaccine, Covovax, as a heterologous booster dose for adults who have..
IndiaTimes - Published

Covovax may get approval as heterologous booster

The government may decide on allowing Serum Institute of India’s (SII) Covovax as a heterologous booster dose, meaning it can be used for people who have taken either Covishield or Covaxin for..
IndiaTimes - Published

Covid situation in India better than elsewhere: SII CEO Adar Poonawalla

Serum Institute CEO Adar Poonawalla on Sunday lauded India's fight against the Covid pandemic, saying the government and the healthcare workers contributed largely to tackling the pandemic. "Everyone..
IndiaTimes - Published

Covid-19: Covovax to get approval as booster in 10-15 days, says SII CEO Adar Poonawalla

Serum Institute of India chief executive officer Adar Poonawalla on Sunday said its Covovax vaccine will get approval as a booster in the next 10 to 15 days, adding it works very well against the..
IndiaTimes - Published


 Page 1  〉